Related Experiment Videos
[Hypertriglyceridemia: an independent risk factor for cardiovascular diseases?]
1II. Medizinischen Universitätsklinik Wien.
Insights
Hypertriglyceridemia, or high triglyceride levels, is an independent risk factor for cardiovascular disease. Even borderline high levels warrant investigation and treatment to mitigate heart disease risks.
Area of Science:
- Cardiology
- Endocrinology
- Epidemiology
Context:
- Hypertriglyceridemia is a common condition with debated cardiovascular implications.
- Understanding its role as an independent risk factor is crucial for public health.
Purpose:
- To review the evidence on whether hypertriglyceridemia independently contributes to cardiovascular disease.
- To present current definitions, causes, and proposed mechanisms of hypertriglyceridemia's atherogenicity.
Summary:
- Epidemiological data indicate hypertriglyceridemia is an independent risk factor for cardiovascular disease, even after adjusting for other known risk factors.
- Recent analyses, including the Framingham study, show significant correlation between elevated triglycerides and coronary heart disease, particularly in women.
- Consensus conferences recommend investigating and treating borderline hypertriglyceridemia through diet and medication.
Impact:
- Highlights the importance of managing high triglyceride levels for cardiovascular risk reduction.
- Informs clinical guidelines and patient management strategies for preventing heart disease.
- Emphasizes the need for proactive screening and intervention for hypertriglyceridemia.
Abstract:
This review deals with the question whether hypertriglyceridemia represents an independent risk factor for the development of cardiovascular disease. The accepted definition of hyper- and "borderline"-hypertriglyceridemia is presented as well as its most frequent causes. After discussion of the hypotheses of the possible ways of mechanisms by which elevated serum triglycerides may be atherogenic the available epidemiologic data are analysed: summarizing these results it can be stated that in contrast to previous statements hypertriglyceridemia seems to be an independent risk factor for the development of cardiovascular disease, even after correction for other risk factors like total cholesterol, smoking, familial history, age or similar well known factors. Even the Framingham study that in earlier studies denied an independent role of the serum triglycerides showed recently that serum triglycerides correlated significantly with coronary heart disease after correction of other risk factors, especially in women. In conclusion, the recommendations of the European and American Consensus Conferences for patients with hypertriglyceridemia are presented: these conferences agree that even borderline hypertriglyceridemia should be investigated for its cause and treated by diet and if this fails by drugs.